understand the resource impact assessment tools available hear from NICE speakers about guidance development and health economics speak to colleagues about how commissioners and service providers can ...
Nipocalimab was well-tolerated over the six-month study period, with no major safety signals observed. The most common adverse events (AEs) were infections and infestations: 60.4% (n=32) in the ...